References
- Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ. 1973;49(1):103.
- Fisher RA. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transplant Infect Dis. 2009 Jun;11(3):195–202.
- Styczynski J, Czyzewski K, Wysocki M, et al. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. Clin Microbiol Infect. 2016 Feb 1;22(2):179–e1.
- Syed R, Rehman A, Valecha G, et al. Pauci-immune crescentic glomerulonephritis: an ANCA-associated vasculitis. Biomed Res Int. 2015;2015.
- Gea-Banacloche JC. Rituximab-associated infections. Semin hematol 2010 Apr 1;47 (2): 187–198. WB Saunders.
- Lim CC, Tung YT, Tan BH, et al. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology. 2018 Jul;23(7):676–681.
- Haag-Weber M, Hörl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol. 1996 May;16(3):192–201.
- Wang HW, Kuo CJ, Lin WR, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016 Jun 1;29(4):392–399.
- Lee G, Kim NI, Gu JT, et al. A case of cytomegalovirus colitis in an immunocompetent adult. Korean J Gastroenterol. 2000 May 1;35(5):649–653.
- Foucar E, Mukai K, Foucar K, et al. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol. 1981 Dec 1;76(6):788–801.
- Nitsche A, Oswald O, Steuer N, et al. Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development? Clin Chem. 2003 Oct 1;49(10):1683–1685.
- Boeckh M, Huang M, Ferrenberg J, et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol. 2004 Mar 1;42(3):1142–1148.
- Torre-Cisneros J, Fariñas MC, Castón JJ, et al. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin. 2011 Dec 1;29(10):735–758.
- van der Kolk LE, Baars JW, Prins MH, et al. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood. 2002 Sep 15;100(6):2257–2259.
- Stasi R, Cooper N, Del Poeta G, et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab. Blood. 2008 Aug 15;112(4):1147–1150.
- Cvetkovic RS, Wellington K. Valganciclovir. Drugs. 2005 Apr 1;65(6):859–878.
- Chou S, Guentzel S, Michels KR, et al. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis. 1995 Jul 1;172(1):239–242.
- El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016 Dec 8;128(23):2624–2636.
- Marty FM, Ljungman P, Chemaly RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017 Dec 21;377(25):2433–2444.